HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The company's HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company's platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors or sales agents in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
NEW YORK, NY / ACCESSWIRE / March 24, 2017 / HTG Molecular found it has passed the necessary technical feasibility tests for its technology to be adopted by a major scientific equipment distributor, while Flexion Therapeutics attracted a major pharmaceutical company's attention with its OA drug. Rumors of a buyout float around investor circles.
I wonder if there's any potential for a post weekend run now that most of the day traders have made their profits. The stock was just at 8.64 and bounced back to 9.65 in a matter of minutes. The potential buyout could send it soaring as well, right?
Agreed. I missed my sell point on Friday due to my phone dying in class (rookie mistake) and was pretty deep in the red for a bit. Luckily today's premarket prices shot it back into the green for me I'm out for now but might jump back in
$HTGM again Monday but then sold off. HTGM is a buy below $8 on the next major correction for a trade.
$HTGM should be watched this week after the major correction. HTGM and SNAP are my top stocks to watch looking forward. China 3x Bull (YINN) and Small Caps 3x Bull (TNA) are strong buys on all major pullbacks in 2017.
$HTGM surged from $7.50-$8.50 on Friday. HTGM is now a buy below $6.50 for a trade. This stock has real momentum and is great or trading right now.
HTGM is trying to form a base around $6 right now. HTGM is now a buy below $6 for the next big trade.
few info to update this stock ..... May-19-17 10:34AM HTG Molecular Diagnostics, Inc. :HTGM-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 Capital Cube May-16-17 04:43PM Edited Transcript of HTGM earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents 12:53PM ETFs with exposure to HTG Molecular Diagnostics, Inc. : May 16, 2017 Capital Cube May-15-17 04:01PM HTG Molecular Diagnostics Reports First Quarter 2017 Results GlobeNewswire 03:00PM Investor Network: HTG Molecular Diagnostics, Inc. to Host Earnings Call Accesswire May-04-17 08:30AM HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017 GlobeNewswire -11.21% May-01-17 04:01PM HTG Molecular Diagnostics to Hold 2017 First Quarter Results Conference Call on May 15, 2017 GlobeNewswire 03:59PM ETFs with exposure to HTG Molecular Diagnostics, Inc. : May 1, 2017 Capital Cube Apr-24-17 08:00AM HTG Molecular Diagnostics and Instituto Valenciano de Oncología Initiate Breast Cancer Recurrence Risk Collaboration GlobeNewswire Apr-17-17 04:01PM HTG Molecular Diagnostics Transfers Listing to The Nasdaq Capital Market GlobeNewswire
Should be touching $2.50 at open and possibly test $.300-$3.15 zone. But parabolic move should arrive within weeks
After a quick catch of breath from the pop you noted, looks like it's ready to resume the upward run.
